Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
To Compare the Pharmacokinetics Profiles of ISO 20, IBU 200 and IBU Plus ISO Combinations 200 + 20 (ISOFEN1)
This study is currently recruiting participants.
Verified November 2011
by Parent Project, Italy
Study NCT01478022 Information provided by Parent Project, Italy
First Received on November 14, 2011. Last Updated on November 22, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Duchenne Muscular Dystrophy (DMD)
Additional conditions recognized in this trial
Muscular Dystrophies
Muscular Dystrophy, Duchenne
More general conditions related to this trial
Genetic Diseases, Inborn
Genetic Diseases, X-Linked
Muscular Diseases
Muscular Disorders, Atrophic
Musculoskeletal Diseases
Nervous System Diseases
Neuromuscular Diseases
Interventions listed in this trial
Isosorbide Dinitrate
Ibuprofen
Additional drug interventions recognized in this trial
Isosorbide
Isosorbide-5-mononitrate
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antirheumatic Agents
Cardiovascular Agents
Central Nervous System Agents
Cyclooxygenase Inhibitors
Diuretics
Diuretics, Osmotic
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Natriuretic Agents
Nitric Oxide Donors
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Parent Project, Italy
Back to top of Main Content